185 related articles for article (PubMed ID: 8542947)
1. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
Sartor M; Bradstock K
Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
Hurwitz CA; Gore SD; Stone KD; Civin CI
Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
[TBL] [Abstract][Full Text] [Related]
5. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
7. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
Rani S; De Oliveira MS; Catovsky D
Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
[TBL] [Abstract][Full Text] [Related]
8. [Acute mixed lineage leukemia showing resistance to AML and ALL therapy].
Kawashima H; Iizuka Y; Kondou W; Hirota H; Okuyama Y; Kanou M; Ichii S; Murakami J; Tsuchiya T; Sawada T
Rinsho Ketsueki; 1993 May; 34(5):643-8. PubMed ID: 7686236
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
11. IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.
Liu S; Bo L; Liu X; Li C; Qin S; Wang J
Cancer Genet Cytogenet; 2004 Jul; 152(2):141-5. PubMed ID: 15262434
[TBL] [Abstract][Full Text] [Related]
12. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56).
Seymour JF; Pierce SA; Kantarjian HM; Keating MJ; Estey EH
Leukemia; 1994 May; 8(5):823-6. PubMed ID: 7514247
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
Echeverri C; Fisher S; King D; Craig FE
Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
[TBL] [Abstract][Full Text] [Related]
15. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
[TBL] [Abstract][Full Text] [Related]
16. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
Koníková E; Kusenda J; Babusíková O; Glasová M
Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
[TBL] [Abstract][Full Text] [Related]
17. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
Maitra A; McKenna RW; Weinberg AG; Schneider NR; Kroft SH
Am J Clin Pathol; 2001 Jun; 115(6):868-75. PubMed ID: 11392884
[TBL] [Abstract][Full Text] [Related]
18. t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia.
Krance RA; Raimondi SC; Dubowy R; Estrada J; Borowitz M; Behm F; Land VJ; Pullen J; Carroll AJ
Leukemia; 1992 Apr; 6(4):251-5. PubMed ID: 1534130
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
